Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Astrocytoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00350727
What this trial is testing

Pazopanib In Combination With Lapatinib In Adult Patients With Relapsed Malignant Glioma

Who this might be right for
Glioma
GlaxoSmithKline 75
Early research (Phase 1)Study completedNCT03389802
What this trial is testing

Phase I Study of APX005M in Pediatric Central Nervous System Tumors

Who this might be right for
Glioblastoma MultiformeHigh-grade Astrocytoma Not Otherwise Specified (NOS)CNS Primary Tumor, Not Otherwise Specified (NOS)+3 more
Pediatric Brain Tumor Consortium 32
Testing effectiveness (Phase 2)Study completedNCT01115491
What this trial is testing

Bevacizumab and Extended Treatment of Temozolomide in Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Hoffmann-La Roche 32
Not applicableActive Not RecruitingNCT07832448
What this trial is testing

Microsurgical Resection Combined With Photodynamic Therapy for Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma (WHO-Grade IV Glioma)
Yonggao Mou 10
Not applicableNo Longer AvailableNCT03311542
What this trial is testing

Expanded Access for Pembrolizumab (MK-3475)

Who this might be right for
Melanoma (Skin)Melanoma RecurrentGlioblastoma Multiforme+2 more
Center Trials & Treatment
Testing effectiveness (Phase 2)UnknownNCT04715620
What this trial is testing

Niraparib Combined With Radiotherapy in rGBM

Who this might be right for
Recurrent Glioblastoma
Tianjin Huanhu Hospital 30
Not applicableStudy completedNCT02575027
What this trial is testing

Palliative 4pi Radiotherapy in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
GlioblastomaRecurrent Brain Neoplasm
Jonsson Comprehensive Cancer Center 10
Early research (Phase 1)UnknownNCT01107522
What this trial is testing

Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas

Who this might be right for
Solid Tumors, Glioblastoma, Recurrent Malignant Gliomas
Tactical Therapeutics, Inc. 100
Early research (Phase 1)Study completedNCT01985256
What this trial is testing

Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaAnaplastic Oligodendroglioma+1 more
Tocagen Inc. 17
Testing effectiveness (Phase 2)Study completedNCT01562197
What this trial is testing

Phase II Clinical Trial on the Efficacy of Axitinib as a Monotherapy or in Combination With Lomustine for the Treatment of Patients With Recurrent Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Bart Neyns 56
Early research (Phase 1)UnknownNCT03722342
What this trial is testing

TTAC-0001 and Pembrolizumab Combination phase1b Trial in Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
PharmAbcine 9
Early research (Phase 1)Ended earlyNCT02133183
What this trial is testing

Sapanisertib Before and After Surgery in Treating Patients With Recurrent Glioblastoma

Who this might be right for
GlioblastomaGliosarcoma
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03743662
What this trial is testing

Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma

Who this might be right for
Glioblastoma
Memorial Sloan Kettering Cancer Center 39
Testing effectiveness (Phase 2)UnknownNCT00014105
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Atlantic Health System
Early research (Phase 1)Study completedNCT00036894
What this trial is testing

CC-5013 in Treating Patients With Recurrent Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT07417761
What this trial is testing

Tuvusertib in Astrocytoma With ATRX Mutation

Who this might be right for
Astrocytoma
Grupo Español de Investigación en Neurooncología 56
Testing effectiveness (Phase 2)WithdrawnNCT03973879
What this trial is testing

Combination of PVSRIPO and Atezolizumab for Adults With Recurrent Malignant Glioma

Who this might be right for
Malignant Glioma
Darell Bigner
Testing effectiveness (Phase 2)Study completedNCT01290263
What this trial is testing

Amgen 386 for Recurrent Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Dana-Farber Cancer Institute 48
Testing effectiveness (Phase 2)Study completedNCT00481455
What this trial is testing

Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM)

Who this might be right for
Recurrent Glioblastoma Multiforme
CASI pharmaceuticals, Inc. 15
Testing effectiveness (Phase 2)Looking for participantsNCT06177964
What this trial is testing

Lerapolturev (PVSRIPO) in GBM

Who this might be right for
Recurrent Supratentorial Glioblastoma
Darell Bigner 92
Next Page